277 related articles for article (PubMed ID: 20123757)
1. A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Bhattacharya S; Conolly RB; Kaminski NE; Thomas RS; Andersen ME; Zhang Q
Toxicol Sci; 2010 May; 115(1):51-65. PubMed ID: 20123757
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
[TBL] [Abstract][Full Text] [Related]
3. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
[TBL] [Abstract][Full Text] [Related]
4. Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin.
Zhang Q; Bhattacharya S; Kline DE; Crawford RB; Conolly RB; Thomas RS; Kaminski NE; Andersen ME
BMC Syst Biol; 2010 Apr; 4():40. PubMed ID: 20359356
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous in vivo time course and dose response evaluation for TCDD-induced impairment of the LPS-stimulated primary IgM response.
North CM; Crawford RB; Lu H; Kaminski NE
Toxicol Sci; 2009 Nov; 112(1):123-32. PubMed ID: 19675145
[TBL] [Abstract][Full Text] [Related]
6. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
Phadnis-Moghe AS; Crawford RB; Kaminski NE
Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
[TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells.
Yoo BS; Boverhof DR; Shnaider D; Crawford RB; Zacharewski TR; Kaminski NE
Toxicol Sci; 2004 Feb; 77(2):272-9. PubMed ID: 14600275
[TBL] [Abstract][Full Text] [Related]
8. All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Zhang Q; Kline DE; Bhattacharya S; Crawford RB; Conolly RB; Thomas RS; Andersen ME; Kaminski NE
Toxicol Appl Pharmacol; 2013 Apr; 268(1):17-26. PubMed ID: 23357550
[TBL] [Abstract][Full Text] [Related]
9. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.
North CM; Crawford RB; Lu H; Kaminski NE
Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231
[TBL] [Abstract][Full Text] [Related]
10. Different kinetics of blimp-1 induction in B cell subsets revealed by reporter gene.
Fairfax KA; Corcoran LM; Pridans C; Huntington ND; Kallies A; Nutt SL; Tarlinton DM
J Immunol; 2007 Apr; 178(7):4104-11. PubMed ID: 17371965
[TBL] [Abstract][Full Text] [Related]
11. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
[TBL] [Abstract][Full Text] [Related]
12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells.
Crawford RB; Sulentic CE; Yoo BS; Kaminski NE
Toxicol Sci; 2003 Oct; 75(2):333-42. PubMed ID: 12883080
[TBL] [Abstract][Full Text] [Related]
13. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
Sulentic CE; Holsapple MP; Kaminski NE
J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
[TBL] [Abstract][Full Text] [Related]
14. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
Sulentic CE; Holsapple MP; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
[TBL] [Abstract][Full Text] [Related]
15. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells.
Lin KI; Angelin-Duclos C; Kuo TC; Calame K
Mol Cell Biol; 2002 Jul; 22(13):4771-80. PubMed ID: 12052884
[TBL] [Abstract][Full Text] [Related]
16. CD40 signaling drives B lymphocytes into an intermediate memory-like state, poised between naïve and plasma cells.
Upadhyay M; Priya GK; Ramesh P; Madhavi MB; Rath S; Bal V; George A; Vaidya T
J Cell Physiol; 2014 Oct; 229(10):1387-96. PubMed ID: 24482285
[TBL] [Abstract][Full Text] [Related]
17. Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene.
Vasanwala FH; Kusam S; Toney LM; Dent AL
J Immunol; 2002 Aug; 169(4):1922-9. PubMed ID: 12165517
[TBL] [Abstract][Full Text] [Related]
18. Regulatory mechanisms that determine the development and function of plasma cells.
Calame KL; Lin KI; Tunyaplin C
Annu Rev Immunol; 2003; 21():205-30. PubMed ID: 12524387
[TBL] [Abstract][Full Text] [Related]
19. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
Jiang H; Gao W; Sze DM; Xiong H; Hou J
Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
[TBL] [Abstract][Full Text] [Related]
20. Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation.
Crotty S; Johnston RJ; Schoenberger SP
Nat Immunol; 2010 Feb; 11(2):114-20. PubMed ID: 20084069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]